Q BioMed Inc. (QBIO)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 284.35 Thousand | 195.59 Thousand | 30 Thousand | - | - | - |
| Cost of Revenue | 293.34 Thousand | 246.84 Thousand | 326 Thousand | 50 Thousand | - | - |
| Gross Profit | -8988.00 | -51.24 Thousand | -296 Thousand | -50 Thousand | - | - |
| Operating Expenses | 3.43 Million | 7.33 Million | 12.84 Million | 8.01 Million | 9.01 Million | 12.37 Million |
| Selling, General and Administrative Expenses | 3.31 Million | 6.26 Million | 10.96 Million | 4.48 Million | 5.78 Million | 9.27 Million |
| Research and Development Expenses | 125.37 Thousand | 1.07 Million | 1.88 Million | 3.53 Million | 3.23 Million | 3.09 Million |
| Other Expenses | 1.00 | - | - | - | - | - |
| Cost and Expenses | 3.72 Million | 7.58 Million | 13.17 Million | 8.01 Million | 9.01 Million | 12.37 Million |
| Operating Income | -3.44 Million | -7.38 Million | -13.14 Million | -8.01 Million | -9.01 Million | -12.37 Million |
| Interest Expense | 1.38 Million | 506.92 Thousand | 296.21 Thousand | 1.46 Million | 162.1 Thousand | 760.31 Thousand |
| Income Tax Expense | - | 506.92 Thousand | 296.21 Thousand | 1.46 Million | 251.1 Thousand | 760.17 Thousand |
| Earnings before Tax | -2.05 Million | -8.24 Million | -13.49 Million | -10.27 Million | -9.27 Million | -14.54 Million |
| Net Income | -2.05 Million | -8.74 Million | -13.78 Million | -11.74 Million | -9.27 Million | -14.54 Million |
| Earnings Per Share Basic | -0.08 | -0.33 | -0.62 | -0.78 | -0.67 | -1.39 |
| Earnings Per Share Diluted | -0.08 | -0.33 | -0.62 | -0.78 | -0.67 | -1.39 |
| Weighted Average Shares Outstanding | 44.75 Million | 26.77 Million | 22.16 Million | 15.04 Million | 13.73 Million | 10.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.75 Million | 26.77 Million | 22.16 Million | 15.04 Million | 13.73 Million | 10.46 Million |
| Gross Margin | -0.03 | -0.26 | -9.87 | - | - | - |
| EBIT Margin | -2.17 | -37.52 | -436.51 | - | - | - |
| Profit Margin | -7.22 | -44.72 | -459.61 | - | - | - |
| EBITDA | -617.62 Thousand | -7.68 Million | -13.14 Million | -7.96 Million | -89 Thousand | -1.4 Million |
| Earnings Before Tax Margin | -12.12 | -37.77 | -438.18 | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 2500.00 | 284.35 Thousand | 12.53 Thousand | 26.27 Thousand |
| Cost of Revenue | - | - | 2500.00 | 293.34 Thousand | 80.2 Thousand | 66.44 Thousand |
| Gross Profit | - | - | - | -8988.00 | -67.66 Thousand | -40.17 Thousand |
| Operating Expenses | - | - | 442.5 Thousand | 3.43 Million | 497.92 Thousand | 740.91 Thousand |
| Selling, General and Administrative Expenses | - | - | 439.81 Thousand | - | 475.7 Thousand | 720.07 Thousand |
| Research and Development Expenses | - | - | 2691.00 | - | 22.21 Thousand | 20.83 Thousand |
| Other Expenses | - | - | 1.00 | 1.00 | - | -4250.00 |
| Cost and Expenses | - | - | 445 Thousand | 3.72 Million | 578.12 Thousand | 807.35 Thousand |
| Operating Income | - | - | -445.01 Thousand | -3.44 Million | 2.58 Million | -781.08 Thousand |
| Interest Expense | - | - | 276.6 Thousand | 1.38 Million | 276.46 Thousand | 240 Thousand |
| Income Tax Expense | - | - | 104.8 Thousand | -1.33 Million | 2923.00 | 14.02 Thousand |
| Earnings before Tax | - | - | -721.61 Thousand | -2.05 Million | 2.3 Million | -795.47 Thousand |
| Net Income | - | - | -826.41 Thousand | -716.09 Thousand | 2.3 Million | -809.5 Thousand |
| Earnings Per Share Basic | - | - | -0.01 | - | 0.03 | -0.02 |
| Earnings Per Share Diluted | - | - | -0.01 | - | 0.03 | -0.02 |
| Weighted Average Shares Outstanding | - | - | 108.73 Million | 44.75 Million | 84.32 Million | 44.89 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | 108.73 Million | 44.75 Million | 84.32 Million | 44.89 Million |
| Gross Margin | - | - | - | -0.03 | -5.40 | -1.53 |
| EBIT Margin | - | - | -173.00 | - | 206.97 | -29.42 |
| Profit Margin | - | - | -330.56 | -2.52 | 183.68 | -30.81 |
| EBITDA | - | - | -432.5 Thousand | - | 2.59 Million | -772.83 Thousand |
| Earnings Before Tax Margin | - | - | -178.00 | -12.12 | 205.97 | -29.73 |
TNXT
CPI
INEP3
603726
3465
ADWPF